Dr Denis Lacombe, Director EORTC Headquarters, spoke with ecancer.tv about the EORTC’s SPECTA, Screening Patients for Efficient Clinical Trial Access, initiative during WIN 2014. He discussed the SPECTA initiative and perspectives for effective cancer drug development.
Dr Lacombe, Director EORTC Headquarters, talks with ecancer.tv about SPECTA during WIN 2014
Methodologies for conducting trials and other studies, including data handling and analysis at ESTRO-EORTC wor... 26/04/2017
27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) – EORTC session: Infections... 06/04/2017